Interestingly, compared to tumor clinical and histopathologic features, we found significant differences across the FTH phenotypes in PR expression, a marker shown to be an indicator of tumor ER functionality and a more differentiated breast cancer biologic phenotype [38]. This evidence concerns the gene ESR1 and breast carcinoma.